chr17-75521455-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_207346.3(TSEN54):​c.568G>A​(p.Val190Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.053 in 1,614,038 control chromosomes in the GnomAD database, including 2,598 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V190L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.041 ( 180 hom., cov: 32)
Exomes 𝑓: 0.054 ( 2418 hom. )

Consequence

TSEN54
NM_207346.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.0780

Publications

16 publications found
Variant links:
Genes affected
TSEN54 (HGNC:27561): (tRNA splicing endonuclease subunit 54) This gene encodes a subunit of the tRNA splicing endonuclease complex, which catalyzes the removal of introns from precursor tRNAs. The complex is also implicated in pre-mRNA 3-prime end processing. Mutations in this gene result in pontocerebellar hypoplasia type 2.[provided by RefSeq, Oct 2009]
TSEN54 Gene-Disease associations (from GenCC):
  • pontocerebellar hypoplasia type 2A
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia
  • pontocerebellar hypoplasia type 4
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia
  • pontocerebellar hypoplasia type 5
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • pontocerebellar hypoplasia type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002036363).
BP6
Variant 17-75521455-G-A is Benign according to our data. Variant chr17-75521455-G-A is described in ClinVar as [Benign]. Clinvar id is 137758.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0557 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSEN54NM_207346.3 linkc.568G>A p.Val190Met missense_variant Exon 7 of 11 ENST00000333213.11 NP_997229.2 Q7Z6J9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSEN54ENST00000333213.11 linkc.568G>A p.Val190Met missense_variant Exon 7 of 11 1 NM_207346.3 ENSP00000327487.6 Q7Z6J9-1

Frequencies

GnomAD3 genomes
AF:
0.0413
AC:
6281
AN:
152188
Hom.:
180
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0102
Gnomad AMI
AF:
0.0615
Gnomad AMR
AF:
0.0324
Gnomad ASJ
AF:
0.0712
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.0474
Gnomad FIN
AF:
0.0801
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0572
Gnomad OTH
AF:
0.0363
GnomAD2 exomes
AF:
0.0471
AC:
11832
AN:
251258
AF XY:
0.0494
show subpopulations
Gnomad AFR exome
AF:
0.00788
Gnomad AMR exome
AF:
0.0247
Gnomad ASJ exome
AF:
0.0739
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0812
Gnomad NFE exome
AF:
0.0575
Gnomad OTH exome
AF:
0.0492
GnomAD4 exome
AF:
0.0543
AC:
79307
AN:
1461732
Hom.:
2418
Cov.:
32
AF XY:
0.0546
AC XY:
39691
AN XY:
727164
show subpopulations
African (AFR)
AF:
0.00726
AC:
243
AN:
33480
American (AMR)
AF:
0.0260
AC:
1162
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0741
AC:
1936
AN:
26136
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39698
South Asian (SAS)
AF:
0.0504
AC:
4350
AN:
86256
European-Finnish (FIN)
AF:
0.0863
AC:
4601
AN:
53310
Middle Eastern (MID)
AF:
0.0335
AC:
193
AN:
5768
European-Non Finnish (NFE)
AF:
0.0573
AC:
63759
AN:
1111970
Other (OTH)
AF:
0.0506
AC:
3057
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
4575
9149
13724
18298
22873
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2350
4700
7050
9400
11750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0412
AC:
6276
AN:
152306
Hom.:
180
Cov.:
32
AF XY:
0.0419
AC XY:
3122
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.0102
AC:
422
AN:
41574
American (AMR)
AF:
0.0323
AC:
495
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0712
AC:
247
AN:
3468
East Asian (EAS)
AF:
0.000579
AC:
3
AN:
5178
South Asian (SAS)
AF:
0.0468
AC:
226
AN:
4828
European-Finnish (FIN)
AF:
0.0801
AC:
851
AN:
10620
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0572
AC:
3891
AN:
68012
Other (OTH)
AF:
0.0360
AC:
76
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
318
636
955
1273
1591
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0466
Hom.:
191
Bravo
AF:
0.0360
TwinsUK
AF:
0.0609
AC:
226
ALSPAC
AF:
0.0568
AC:
219
ESP6500AA
AF:
0.0116
AC:
51
ESP6500EA
AF:
0.0574
AC:
494
ExAC
AF:
0.0479
AC:
5814
Asia WGS
AF:
0.0120
AC:
40
AN:
3478
EpiCase
AF:
0.0511
EpiControl
AF:
0.0489

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 15, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:4
-
Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Pontoneocerebellar hypoplasia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
6.4
DANN
Benign
0.44
DEOGEN2
Benign
0.018
T
Eigen
Benign
-0.99
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.079
N
LIST_S2
Benign
0.58
T
MetaRNN
Benign
0.0020
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.69
N
PhyloP100
0.078
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.47
N
REVEL
Benign
0.085
Sift
Benign
0.12
T
Sift4G
Benign
0.12
T
Polyphen
0.95
P
Vest4
0.037
MPC
0.26
ClinPred
0.0063
T
GERP RS
-1.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.023
gMVP
0.25
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79508780; hg19: chr17-73517536; API